RNAConnectĀ® Launches UltraMarathonRTĀ® Kit to Transform Short-Read RNA Sequencing
RNAConnect today announced the commercial launch of the UltraMarathonRTĀ® (uMRT) cDNA Synthesis and Amplification Kit, a next-generation tool designed...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Prescription, Generic, and Over-The-Counter: Drugs & Products.
RNAConnect today announced the commercial launch of the UltraMarathonRTĀ® (uMRT) cDNA Synthesis and Amplification Kit, a next-generation tool designed...
SHIRLEY, N.Y., August 27, 2025 ā American Regent, Inc.Ā® has announced the commercial launch of Gvoke VialDx⢠(glucagon injection),...
PharmaTher Holdings Ltd. announced FDA approval of KETARxā¢, its ketamine product for anesthesia and sedation, marking a significant milestone...
Mahwah, New Jersey, August 19, 2025 ā Glenmark Pharmaceuticals Inc., USA is set to introduce Micafungin for Injection USP...
